Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference

Rhea-AI Summary

Bausch + Lomb CEO to participate in 2023 Wells Fargo Healthcare Conference

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders is scheduled to participate at the 2023 Wells Fargo Healthcare Conference in Boston on Sept. 6, 2023, at 10:15 a.m. ET.

A live webcast and audio archive of the conference will be available on the Investor Relations section of the Bausch + Lomb website.

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.

^© 2023 Bausch + Lomb.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230829780658/en/

Media Contacts:

T.J. Crawford

tj.crawford@bausch.com

(908) 705-2851

Lainie Keller

lainie.keller@bausch.com

(908) 927-1198

Investor Contacts:

George Gadkowski

george.gadkowski@bausch.com

Allison Ryan

allison.ryan@bausch.com

(877) 354-3705 (toll free)

(908) 927-0735

Source: Bausch + Lomb Corporation